Nanotechnology in Vaccine Delivery
Nanotechnology in Vaccine Delivery has revolutionized the way vaccines are formulated and administered, offering enhanced precision and efficacy. One of the most notable advancements is the use of lipid nanoparticles, which protect mRNA or antigen payloads and ensure targeted delivery to immune cells. These nanoparticles improve vaccine stability, bioavailability, and reduce degradation during transport in the body. LNP-based delivery played a key role in the success of recent mRNA COVID-19 vaccines. This technology continues to evolve, offering promise for next-generation vaccines against cancer, HIV, and emerging infectious diseases.
- Lipid nanoparticles
- Targeted delivery systems
- Nano-adjuvants
- Microneedle patches
Related Conference of Nanotechnology in Vaccine Delivery
March 24-25, 2026
9th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
August 27-28, 2026
7th International conference on Vaccines, Vaccination and Immunization
Paris, France
Nanotechnology in Vaccine Delivery Conference Speakers
Recommended Sessions
- Adjuvants and Immunopotentiators
- Adult and Elderly Vaccination Strategies
- AI and Data Science in Vaccine Discovery
- Antimicrobial Resistance and Vaccines
- Booster Doses and Heterologous Vaccine Regimens
- Cancer Vaccines and Immunotherapy
- Corporate Innovation, Sponsorship & Exhibition
- COVID-19 Vaccine Impact and Learnings
- Global Immunization Programs and Policy
- Infectious Disease Vaccines
- Manufacturing, Supply Chain, and Distribution
- Nanotechnology in Vaccine Delivery
- Next-Generation Vaccine Technologies
- Pediatric and Neonatal Vaccines
- Vaccine Research Ethics and Regulations
- Vaccine Safety and Pharmacovigilance
- Veterinary and Zoonotic Vaccines
- Workshops and Poster Sessions
Related Journals
Are you interested in
- Adjuvants and Immunopotentiators - VACCINE CONGRESS 2025 (Japan)
- Adult and Elderly Vaccination Strategies - VACCINE CONGRESS 2025 (Japan)
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Adverse reactions to the vaccination - Vaccines Congress-2025 (Canada)
- AI and Data Science in Vaccine Discovery - VACCINE CONGRESS 2025 (Japan)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Antimicrobial Resistance and Vaccines - VACCINE CONGRESS 2025 (Japan)
- Antinatal vaccinations - Vaccines Congress-2025 (Canada)
- Booster Doses and Heterologous Vaccine Regimens - VACCINE CONGRESS 2025 (Japan)
- Cancer Vaccines and Immunotherapy - VACCINE CONGRESS 2025 (Japan)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Conjugated and combination vaccinations - Vaccines Congress-2025 (Canada)
- Corporate Innovation, Sponsorship & Exhibition - VACCINE CONGRESS 2025 (Japan)
- COVID-19 Vaccine Impact and Learnings - VACCINE CONGRESS 2025 (Japan)
- Creation and development of vaccines - Vaccines Congress-2025 (Canada)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- DNA, RNA & SYNTHETIC VACCINES - Vaccines Congress-2025 (Canada)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Immunization Programs and Policy - VACCINE CONGRESS 2025 (Japan)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- HIV , Malaria & TB vaccines - Vaccines Congress-2025 (Canada)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Infectious Disease Vaccines - VACCINE CONGRESS 2025 (Japan)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Manufacturing, Supply Chain, and Distribution - VACCINE CONGRESS 2025 (Japan)
- Nanotechnology in Vaccine Delivery - VACCINE CONGRESS 2025 (Japan)
- Next-Generation Vaccine Technologies - VACCINE CONGRESS 2025 (Japan)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Pediatric and Neonatal Vaccines - VACCINE CONGRESS 2025 (Japan)
- rDNA technology in vaccine development - Vaccines Congress-2025 (Canada)
- Recent advances in vaccine development - Vaccines Congress-2025 (Canada)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- The COVID-19 vaccine's next-generation RNA platforms and mRNA - Vaccines Congress-2025 (Canada)
- Toxoid vaccination - Vaccines Congress-2025 (Canada)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine and Vaccination - Vaccines Congress-2025 (Canada)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine efficiency and well-being - Vaccines Congress-2025 (Canada)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine for infectious illnesses in humans - Vaccines Congress-2025 (Canada)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine manufacturing technologies - Vaccines Congress-2025 (Canada)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Research and Clinical trials - Vaccines Congress-2025 (Canada)
- Vaccine Research Ethics and Regulations - VACCINE CONGRESS 2025 (Japan)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine Safety and Pharmacovigilance - VACCINE CONGRESS 2025 (Japan)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines against non-traditional illnesses - Vaccines Congress-2025 (Canada)
- VACCINES FOR CANCER - Vaccines Congress-2025 (Canada)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)
- Veterinary and Zoonotic Vaccines - VACCINE CONGRESS 2025 (Japan)
- Workshops and Poster Sessions - VACCINE CONGRESS 2025 (Japan)
- Zika Virus vaccines - Vaccines Congress-2025 (Canada)